Desflurane - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for desflurane and what is the scope of patent protection?
Desflurane
is the generic ingredient in two branded drugs marketed by Shanghai Hengrui and Baxter Hlthcare, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for desflurane. Four suppliers are listed for this compound.
Summary for desflurane
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 3 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 55 |
Clinical Trials: | 256 |
Patent Applications: | 2,311 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in desflurane? | desflurane excipients list |
DailyMed Link: | desflurane at DailyMed |
Recent Clinical Trials for desflurane
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ajou University School of Medicine | N/A |
Jason Chui | Phase 4 |
King Saud Medical City | Phase 3 |
Pharmacology for desflurane
Drug Class | General Anesthetic |
Physiological Effect | General Anesthesia |
Anatomical Therapeutic Chemical (ATC) Classes for desflurane
Paragraph IV (Patent) Challenges for DESFLURANE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SUPRANE | Inhalation | desflurane | 99.9% | 020118 | 1 | 2008-09-11 |
US Patents and Regulatory Information for desflurane
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | SUPRANE | desflurane | LIQUID;INHALATION | 020118-001 | Sep 18, 1992 | AN | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Shanghai Hengrui | DESFLURANE | desflurane | LIQUID;INHALATION | 208234-001 | Feb 26, 2018 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for desflurane
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare | SUPRANE | desflurane | LIQUID;INHALATION | 020118-001 | Sep 18, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Baxter Hlthcare | SUPRANE | desflurane | LIQUID;INHALATION | 020118-001 | Sep 18, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.